Thiaretic 25 mg Tablets
PDF Leaflet Revision Date: 27 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Oedema, hypertension, diabetes insipidus.
Dosage (summary)
Adults: 25-100 mg daily; max 200 mg. Pediatric: 2.5 mg/kg daily.
Onset of Action / Duration
Onset: 2 hours, Duration: 12 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in 2nd/3rd trimester and lactation.
Key Drug Interactions
- Lithium
- Antidiabetic agents
- Digitalis glycosides
Contraindications
- Hypersensitivity to hydrochlorothiazide
- Anuria
- Severe renal impairment
- Severe hepatic impairment
- Addison's disease
- Hypercalcaemia
Common side effects
- Hypokalaemia
- Hyperglycaemia
- Gout
- Anorexia
Counselling Points
- Monitor blood pressure regularly
- Stay hydrated
- Report skin changes
- Avoid sun exposure
Serious warnings
- Risk of non-melanoma skin cancer
- Severe cutaneous adverse reactions
- Electrolyte imbalance
Important Disclaimer
The Thiaretic 25 mg Tablets professional information leaflet below is the property of Gulf Drug Company and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
